tiprankstipranks
Yuki Gosei Kogyo Co., Ltd. (JP:4531)
:4531
Japanese Market
Want to see JP:4531 full AI Analyst Report?

Yuki Gosei Kogyo Co., Ltd. (4531) AI Stock Analysis

0 Followers

Top Page

JP:4531

Yuki Gosei Kogyo Co., Ltd.

(4531)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 5.2)
Rating:59Neutral
Price Target:
¥379.00
▲(19.56% Upside)
Action:Reiterated
Date:06/03/26
The score is mainly driven by mixed fundamentals: a solid balance sheet and improved 2026 cash flow are offset by a sharp 2026 earnings decline and prior cash-flow inconsistency. Technicals are also mixed with negative MACD and near-overbought momentum readings, while valuation looks somewhat expensive despite a moderate dividend yield.
Positive Factors
Multi-year revenue growth
Sustained multi-year revenue expansion into 2025 shows underlying demand for the firm's specialty chemicals across pharma, agriculture and industrial end-markets. That track record supports customer relationships, scale advantages and continued product development leverage even if near-term sales softened.
Negative Factors
Sharp 2026 earnings decline
A large, single-year drop in net income materially weakens internal profitability and cash accrual capacity. Persistent margin pressure or recurring earnings weakness would erode return on capital, limit funding for R&D and capex, and could force tougher cost or pricing responses across core specialty product lines.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year revenue growth
Sustained multi-year revenue expansion into 2025 shows underlying demand for the firm's specialty chemicals across pharma, agriculture and industrial end-markets. That track record supports customer relationships, scale advantages and continued product development leverage even if near-term sales softened.
Read all positive factors

Yuki Gosei Kogyo Co., Ltd. (4531) vs. iShares MSCI Japan ETF (EWJ)

Yuki Gosei Kogyo Co., Ltd. Business Overview & Revenue Model

Company Description
Yuki Gosei Kogyo Co., Ltd. is a Japanese enterprise that globally researches, develops, produces, and markets sophisticated fine chemical products. Their diverse portfolio encompasses food-grade additives, pharmaceutical components, and chemicals ...
How the Company Makes Money
Yuki Gosei Kogyo Co., Ltd. generates revenue through the production and sale of its specialized chemical products. The company primarily caters to industries requiring high-quality intermediates for drug development, specialty fertilizers, and ind...

Yuki Gosei Kogyo Co., Ltd. Financial Statement Overview

Summary
Multi-year revenue and profitability improved into 2025, but 2026 shows a clear slowdown (revenue down) and a sharp earnings step-down. Balance sheet is relatively solid with equity above debt, though debt rose and remains elevated. Cash flow rebounded strongly in 2026 to positive free cash flow after several negative years, but prior volatility limits confidence.
Income Statement
61
Positive
Balance Sheet
68
Positive
Cash Flow
54
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue15.86B15.45B15.13B12.93B12.84B12.36B
Gross Profit3.19B2.55B3.23B3.26B3.05B2.36B
EBITDA1.93B1.62B2.23B1.93B1.56B1.18B
Net Income708.00M313.00M896.00M776.00M556.00M248.00M
Balance Sheet
Total Assets27.35B25.73B27.29B24.75B22.35B21.38B
Cash, Cash Equivalents and Short-Term Investments1.05B885.00M973.00M588.00M1.14B1.86B
Total Debt9.06B6.71B8.51B6.87B5.58B5.54B
Total Liabilities14.31B12.24B14.18B12.31B10.87B10.38B
Stockholders Equity13.03B13.49B13.11B12.43B11.48B11.00B
Cash Flow
Free Cash Flow0.001.72B-1.20B-1.37B-490.00M1.40B
Operating Cash Flow0.002.84B2.14B388.00M668.00M1.79B
Investing Cash Flow0.00-1.01B-3.25B-1.89B-1.24B-442.00M
Financing Cash Flow0.00-1.92B1.50B948.00M-158.00M-772.00M

Yuki Gosei Kogyo Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price317.00
Price Trends
50DMA
366.18
Negative
100DMA
397.74
Negative
200DMA
338.59
Positive
Market Momentum
MACD
-1.42
Negative
RSI
44.27
Neutral
STOCH
23.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4531, the sentiment is Negative. The current price of 317 is below the 20-day moving average (MA) of 351.25, below the 50-day MA of 366.18, and below the 200-day MA of 338.59, indicating a neutral trend. The MACD of -1.42 indicates Negative momentum. The RSI at 44.27 is Neutral, neither overbought nor oversold. The STOCH value of 23.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4531.

Yuki Gosei Kogyo Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥116.67B45.200.67%8.51%-17.90%
73
Outperform
¥8.74B2.701.96%0.78%171.25%
70
Outperform
¥188.31B10.214.09%-2.00%23.48%
63
Neutral
¥13.81B10.683.89%-0.65%-0.09%
63
Neutral
¥16.60B20.401.81%4.46%-3.54%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
59
Neutral
¥7.53B23.822.97%2.12%-64.98%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4531
Yuki Gosei Kogyo Co., Ltd.
342.00
83.54
32.32%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
3,730.00
591.38
18.84%
JP:4041
Nippon Soda Co., Ltd.
3,480.00
629.69
22.09%
JP:4093
Toho Acetylene Co., Ltd.
394.00
50.85
14.82%
JP:4366
Daito Chemix Corporation
502.00
273.74
119.93%
JP:4970
Toyo Gosei Co., Ltd.
15,010.00
10,353.72
222.36%

Yuki Gosei Kogyo Co., Ltd. Corporate Events

Yuki Gosei Kogyo Profit Slides Despite Higher Sales, Keeps Dividend and Flags Geopolitical Uncertainty
May 15, 2026
Yuki Gosei Kogyo reported a 2.1% rise in net sales to ¥15,448 million for the fiscal year ended March 31, 2026, but operating income plunged 68.4% and net income fell 65.1%, squeezing profitability metrics such as return on equity and operati...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 03, 2026